Health Care
135 companies across 10 industries Β· combined market cap $7.58T
Median revenue growth
8.4%
Median operating margin
13.1%
Median fcf margin
12.8%
Median return on capital
11.2%
Median p/e
28.1x
Health Care Equipment Β· 29
| Company | Market cap | Revenue | Growth | Op. margin | ROIC | P/E | Day |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | $181.2B | $44.3B | 5.7% | 18.2% | 11.2% | 29.0x | 1.2% |
| Intuitive Surgical ISRG | $159.0B | $10.1B | 20.5% | 29.3% | 20.9% | 54.8x | 1.9% |
| Medtronic MDT | $122.6B | $36.4B | 8.4% | 17.8% | 7.7% | 23.4x | 1.2% |
| Stryker SYK | $118.6B | $25.1B | 11.2% | 19.5% | 11.3% | 31.8x | 0.0% |
| Boston Scientific BSX | $67.4B | $20.1B | 19.9% | 18.0% | 9.6% | 18.5x | 0.7% |
| Becton Dickinson BDX | $54.7B | $21.8B | 8.2% | 11.8% | 5.5% | 59.9x | 0.8% |
| Edwards Lifesciences EW | $51.4B | $6.1B | 11.6% | 20.8% | 15.7% | 51.2x | 1.1% |
| Idexx Laboratories IDXX | $44.4B | $4.3B | 10.4% | 31.6% | 57.3% | 39.4x | 1.1% |
| ResMed | RMD | $36.9B | $5.7B | 9.9% | 33.4% | 26.7% | 24.2x | 0.1% |
| GE HealthCare GEHC | $32.7B | $20.6B | 4.8% | 13.4% | 13.3% | 17.1x | 0.0% |
| Dexcom DXCM | $30.4B | $4.7B | 15.6% | 19.6% | 44.9% | 30.9x | 0.5% |
| Steris STE | $22.7B | $5.9B | 8.7% | 18.6% | 9.6% | 28.4x | 0.0% |
| Zimmer Biomet ZBH | $19.0B | $8.2B | 7.2% | 13.3% | 4.9% | 23.9x | 0.3% |
| Revvity RVTY | $17.7B | $2.9B | 3.7% | 12.5% | 3.3% | 76.0x | 0.9% |
| Baxter International BAX | $13.1B | $11.2B | 5.7% | β2.7% | β1.4% | β | 1.4% |
| Penumbra PEN | $12.8B | $1.4B | 17.5% | 13.5% | 18.8% | 79.7x | 0.2% |
| Globus Medical GMED | $11.2B | $2.9B | 16.7% | 16.3% | 11.0% | 20.9x | 0.3% |
| Glaukos GKOS | $10.5B | $507M | 32.3% | β39.3% | β | β | 1.2% |
| Insulet PODD | $10.3B | $2.7B | 30.7% | 17.5% | 20.4% | 27.9x | 0.6% |
| Bruker BRKR | $8.8B | $3.4B | 2.1% | 2.0% | 0.9% | β | 0.5% |
| LivaNova LIVN | $4.6B | $1.4B | 10.7% | 14.4% | 12.8% | 23.9x | 0.5% |
| Integer ITGR | $4.3B | $1.9B | 8.0% | 11.9% | 6.6% | 34.7x | 0.0% |
| LeMaitre Vascular LMAT | $2.1B | $250M | 13.5% | 27.2% | 25.5% | 29.6x | 1.0% |
| Inspire Medical Systems INSP | $2.1B | $912M | 13.6% | 5.6% | 14.2% | 15.7x | 2.1% |
| CONMED CNMD | $1.5B | $1.4B | 5.2% | 7.5% | 3.7% | 32.6x | 0.4% |
| Enovis ENOV | $1.2B | $2.2B | 6.7% | β50.0% | β26.9% | β | 2.4% |
| Artivion AORT | $1.1B | $441M | 13.6% | 7.7% | 3.9% | β | 2.8% |
| Integra Lifesciences IART | $936M | $1.6B | 1.5% | β30.2% | β22.0% | 70.1x | 3.4% |
| AdaptHealth AHCO | $819M | $3.2B | β0.5% | 2.8% | 2.1% | β | 2.4% |
Biotechnology Β· 22
| Company | Market cap | Revenue | Growth | Op. margin | ROIC | P/E | Day |
|---|---|---|---|---|---|---|---|
| AbbVie ABBV | $505.9B | $61.2B | 8.6% | 24.7% | 15.7% | 80.7x | 0.2% |
| Amgen AMGN | $239.0B | $36.8B | 10.0% | 24.7% | 14.4% | 27.3x | 1.8% |
| Gilead Sciences GILD | $194.0B | $29.4B | 2.4% | 34.0% | 23.0% | β | 0.7% |
| Vertex Pharmaceuticals VRTX | $133.7B | $12.0B | 8.9% | 34.8% | 31.5% | 30.5x | 2.1% |
| Regeneron Pharmaceuticals REGN | $85.3B | $14.3B | 1.0% | 25.0% | 12.7% | 19.9x | 1.7% |
| Moderna MRNA | $79.6B | $1.9B | β39.9% | β158.1% | β65.4% | β | 1.2% |
| Biogen BIIB | $37.2B | $9.9B | 2.2% | β | 7.3% | 27.0x | 1.2% |
| United Therapeutics UTHR | $26.9B | $3.2B | 10.6% | 46.9% | β | 21.0x | 0.5% |
| Roivant Sciences ROIV | $26.3B | $8.3M | β71.6% | β6,235.7% | β62.6% | β | 2.6% |
| Incyte INCY | $23.9B | $5.1B | 21.2% | 29.5% | 79.4% | 16.3x | 1.0% |
| Exelixis EXEL | $16.8B | $2.3B | 7.0% | 37.6% | 64.9% | 20.3x | 1.2% |
| Halozyme HALO | $15.2B | $1.4B | 37.6% | 33.6% | 19.2% | 36.6x | 0.9% |
| Neurocrine Biosciences NBIX | $14.9B | $2.9B | 21.5% | 21.6% | 25.6% | 20.9x | 0.4% |
| BioMarin Pharmaceutical BMRN | $10.9B | $3.2B | 12.9% | 12.7% | 5.8% | 151.2x | 1.2% |
| Krystal Biotech KRYS | $9.6B | $389M | 33.9% | 41.5% | 43.6% | 39.0x | 2.7% |
| Arrowhead Pharmaceuticals ARWR | $8.3B | $829M | 23,258.2% | 11.9% | β | β | 0.6% |
| Ligand Pharmaceuticals LGND | $6.6B | $268M | 60.4% | 15.3% | 4.9% | 32.3x | 1.4% |
| ADMA Biologics ADMA | $2.5B | $510M | 19.6% | 37.5% | 39.5% | 15.3x | 2.5% |
| Fortrea FTRE | $2.2B | $2.7B | 1.0% | β32.0% | β36.2% | β | 1.2% |
| Harmony Biosciences HRMY | $2.1B | $869M | 21.5% | 24.0% | 48.9% | 11.7x | 0.3% |
| Repligen RGEN | β | $738M | 16.4% | 7.5% | 2.4% | β | 1.0% |
| Cytokinetics CYTK | β | $88.0M | 376.6% | β695.4% | β | β | 1.8% |
Pharmaceuticals Β· 21
| Company | Market cap | Revenue | Growth | Op. margin | ROIC | P/E | Day |
|---|---|---|---|---|---|---|---|
| Eli Lilly LLY | $1.14T | $65.2B | 44.7% | β | 40.8% | 42.7x | 2.5% |
| Johnson & Johnson JNJ | $646.0B | $94.2B | 6.1% | β | 28.6% | 40.0x | 1.4% |
| Merck MRK | $358.8B | $65.0B | 1.3% | β | 24.8% | 115.3x | 1.3% |
| AstraZeneca AZN | $267.9B | $58.7B | 8.6% | 23.4% | 16.8% | β | οΏ½οΏ½ |
| Pfizer PFE | $171.1B | $62.6B | β1.7% | β | 7.3% | 39.5x | 1.3% |
| Bristol Myers Squibb BMY | $125.9B | $48.2B | β0.2% | β | 15.2% | 13.5x | 2.4% |
| Teva Pharmaceuticals TEVA | $45.9B | $17.3B | 4.3% | 12.5% | 10.5% | 65.7x | 2.0% |
| Zoetis ZTS | $33.8B | $9.5B | 2.3% | β | 29.3% | 13.4x | 1.2% |
| Viatris VTRS | $20.9B | $14.3B | β3.0% | β18.6% | β7.1% | β | 2.6% |
| Jazz Pharmaceuticals JAZZ | $14.9B | $4.3B | 4.9% | β10.1% | β4.2% | 14.6x | 0.3% |
| Elanco ELAN | $11.4B | $4.7B | 6.2% | β | β0.1% | β | 0.7% |
| Corcept Therapeutics CORT | $10.2B | $761M | 12.8% | 5.9% | 15.7% | β | 20.1% |
| Alkermes ALKS | $7.6B | $1.5B | β5.3% | 17.2% | β | 114.8x | 1.2% |
| Amneal Pharmaceuticals AMRX | $6.7B | $3.0B | 8.1% | 13.1% | 16.1% | 41.6x | 0.5% |
| Indivior INDV | $4.3B | $1.2B | 4.3% | 21.2% | β | 12.4x | 2.4% |
| Acadia Pharmaceuticals ACAD | $3.4B | $1.1B | 11.9% | 9.8% | β | 8.9x | 2.9% |
| Bausch Health Companies BHC | $2.4B | $10.3B | 6.7% | 17.7% | 4.5% | β | 0.8% |
| ANI Pharmaceuticals ANIP | $1.6B | $883M | 43.8% | 12.6% | 15.9% | 15.7x | 1.5% |
| Innoviva INVA | $1.5B | $411M | 14.7% | 39.8% | 17.9% | 5.0x | 1.9% |
| Amphstar Pharmaceuticals AMPH | $1.1B | $720M | β1.7% | 19.5% | 9.9% | 14.9x | 3.5% |
| Collegium Pharmaceutical COLL | $746M | $781M | 23.6% | 23.0% | 53.4% | 18.5x | 2.3% |
Health Care Services Β· 16
| Company | Market cap | Revenue | Growth | Op. margin | ROIC | P/E | Day |
|---|---|---|---|---|---|---|---|
| CVS Health CVS | $120.3B | $402.1B | 7.9% | 1.2% | 2.9% | 24.6x | 1.1% |
| Cigna CI | $81.0B | $274.9B | 11.2% | 3.4% | 11.7% | 12.7x | 2.8% |
| Quest Diagnostics DGX | $27.1B | $11.0B | 11.8% | 14.1% | 9.5% | 24.1x | 0.6% |
| Labcorp LH | $27.0B | $14.0B | 7.3% | 9.9% | 8.2% | 27.2x | 0.3% |
| BrightSpring Health Services BTSG | $13.2B | $12.9B | 28.2% | 2.3% | 5.3% | 36.2x | 1.2% |
| DaVita DVA | $12.1B | $13.6B | 6.5% | 15.0% | 17.6% | 15.1x | 1.3% |
| Chemed CHE | $6.8B | $2.5B | 4.1% | 13.4% | 27.3% | 25.8x | 1.4% |
| Hims & Hers Health HIMS | $6.4B | $2.3B | 59.0% | 4.5% | 19.0% | β | 4.9% |
| Sotera Health SHC | $5.2B | $1.2B | 5.7% | β | 6.7% | 31.8x | 0.2% |
| Concentra Group Holdings Parent CON | $5.0B | $2.2B | 13.9% | 15.4% | 14.9% | 25.3x | 1.8% |
| Lifestance Health LFST | $5.0B | $1.4B | 13.9% | 1.7% | 1.2% | 99.5x | 2.9% |
| CorVel CRVL | $4.3B | $959M | 7.0% | β | β | 37.3x | 0.0% |
| Addus HomeCare ADUS | $2.3B | $1.4B | 23.2% | 9.7% | 9.4% | 21.3x | 0.7% |
| Amn Healthcare Services AMN | $1.9B | $2.7B | β8.5% | β2.0% | β2.8% | 17.9x | 2.5% |
| Alignment Healthcare ALHC | $1.7B | $3.9B | 46.1% | 0.4% | β | 42.4x | 4.4% |
| Tempus AI TEM | $13.5M | $1.3B | 83.4% | β19.9% | β | β | 6.0% |
Life Sciences Tools & Services Β· 13
| Company | Market cap | Revenue | Growth | Op. margin | ROIC | P/E | Day |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific TMO | $250.0B | $44.6B | 3.9% | 17.4% | 9.1% | 36.3x | 0.4% |
| Danaher DHR | $162.9B | $24.6B | 2.9% | 19.1% | 6.1% | 37.7x | 0.3% |
| Agilent Technologies A | $49.0B | $6.9B | 6.7% | 21.3% | 16.5% | 34.1x | 0.5% |
| IQVIA IQV | $47.4B | $16.3B | 5.9% | 13.4% | 9.5% | 34.7x | 0.4% |
| Waters WAT | $44.6B | $3.2B | 7.0% | 25.4% | 21.0% | β | 0.4% |
| Illumina ILMN | $41.2B | $4.3B | β0.7% | 18.6% | 20.3% | 50.3x | 0.0% |
| Mettler Toledo MTD | $33.7B | $4.0B | 4.0% | β | 50.5% | 37.6x | 0.9% |
| Medpace MEDP | $19.0B | $2.5B | 20.0% | 21.1% | β | 37.2x | 2.3% |
| Charles River Laboratories CRL | $16.6B | $4.0B | β0.9% | 0.6% | 0.4% | β | 1.7% |
| Avantor AVTR | $11.7B | $6.6B | β3.4% | β3.8% | β2.1% | β | 0.8% |
| Bio-Techne TECH | $11.4B | $1.2B | β0.4% | 20.7% | 9.2% | 62.5x | 0.1% |
| Bio-Rad Laboratories BIO | $9.9B | $2.6B | 0.7% | 1.8% | 0.5% | 46.3x | 1.8% |
| Azenta AZTA | $1.7B | $594M | 3.6% | β4.5% | β | β | 1.4% |
Health Care Supplies Β· 10
| Company | Market cap | Revenue | Growth | Op. margin | ROIC | P/E | Day |
|---|---|---|---|---|---|---|---|
| Alcon ALC | $34.8B | $10.4B | 4.9% | 13.1% | 4.6% | β | οΏ½οΏ½ |
| West Pharmaceutical Services WST | $28.0B | $3.1B | 6.3% | 19.0% | 18.7% | 50.2x | 0.5% |
| Cooper Companies COO | $11.8B | $4.1B | 5.1% | 16.7% | 4.3% | 21.0x | 0.7% |
| Align Technology ALGN | $11.0B | $4.0B | 0.9% | 13.5% | 13.3% | 26.9x | 0.6% |
| Lantheus LNTH | $6.7B | $1.5B | 0.5% | 20.2% | 22.7% | 24.2x | 0.3% |
| Haemonetics HAE | $5.4B | $1.3B | β2.0% | 11.8% | 6.7% | 57.3x | 2.0% |
| ICU Medical ICUI | $4.2B | $2.2B | β6.3% | 1.9% | 0.7% | 140.0x | 1.0% |
| Envista NVST | $3.9B | $2.7B | 8.3% | 8.0% | 3.2% | 40.7x | 1.5% |
| Dentsply Sirona XRAY | $1.9B | $3.7B | β3.0% | β11.5% | β9.9% | β | 0.7% |
| BioLife Solutions BLFS | β | $96.2M | 28.9% | β17.3% | β4.8% | β | οΏ½οΏ½ |
Health Care Facilities Β· 8
| Company | Market cap | Revenue | Growth | Op. margin | ROIC | P/E | Day |
|---|---|---|---|---|---|---|---|
| HCA Healthcare HCA | $106.3B | $75.6B | 7.1% | β | 22.3% | 16.2x | 0.4% |
| Tenet Health THC | $22.5B | $21.3B | 3.1% | 16.5% | 18.3% | 10.4x | 0.8% |
| Encompass Health EHC | $12.4B | $5.9B | 10.5% | β | 15.8% | 20.2x | 1.5% |
| Universal Health Services UHS | $11.2B | $17.4B | 9.7% | 11.5% | 13.1% | 7.6x | 0.7% |
| Ensign Group ENSG | $10.4B | $5.1B | 18.7% | 8.4% | 19.7% | 27.5x | 1.5% |
| Option Care Health OPCH | $4.9B | $5.6B | 13.0% | 6.0% | 11.4% | 24.4x | 0.2% |
| Acadia Healthcare ACHC | $2.9B | $3.3B | 5.0% | β | β16.0% | β | 1.2% |
| Astrana Health ASTH | $1.9B | $3.2B | 56.4% | 2.5% | 4.2% | 45.1x | 1.5% |
Managed Health Care Β· 7
| Company | Market cap | Revenue | Growth | Op. margin | ROIC | P/E | Day |
|---|---|---|---|---|---|---|---|
| UnitedHealth UNH | $378.8B | $447.6B | 11.8% | 4.2% | 11.2% | 26.9x | 1.6% |
| Elevance Health ELV | $95.7B | $199.1B | 12.5% | 3.6% | 15.2% | 18.7x | 1.2% |
| Humana HUM | $50.9B | $129.7B | 10.1% | 2.1% | 25.7% | 45.0x | 0.3% |
| Centene CNC | $34.9B | $194.8B | 19.4% | β3.9% | β26.4% | β | 1.5% |
| Molina Healthcare MOH | $10.8B | $45.4B | 11.8% | 1.7% | β | β | 3.5% |
| Oscar Health OSCR | $10.3B | $11.7B | 27.5% | β3.4% | β | 23.8x | 7.0% |
| HealthEquity HQY | $8.7B | $1.3B | 9.5% | 24.6% | 8.9% | 37.5x | 3.0% |
Health Care Technology Β· 5
| Company | Market cap | Revenue | Growth | Op. margin | ROIC | P/E | Day |
|---|---|---|---|---|---|---|---|
| Veeva Systems VEEV | $53.3B | $3.2B | 16.3% | 28.7% | β | 52.9x | 0.2% |
| Solventum SOLV | $14.8B | $8.3B | 0.9% | 26.2% | 20.4% | 10.5x | 2.3% |
| Doximity DOCS | $6.4B | $645M | 13.1% | 33.3% | 91.3% | 39.3x | 0.9% |
| Certara CERT | $1.6B | $419M | 8.8% | 5.0% | 0.9% | β | 2.4% |
| HealthStream HSTM | $1.0B | $304M | 4.3% | 6.7% | β | 48.8x | 1.6% |
Health Care Distributors Β· 4
| Company | Market cap | Revenue | Growth | Op. margin | ROIC | P/E | Day |
|---|---|---|---|---|---|---|---|
| McKesson MCK | $119.3B | $403.4B | 12.4% | 1.5% | β | 26.8x | 1.1% |
| Cencora COR | $64.2B | $321.3B | 9.3% | 0.8% | β | 24.6x | 2.2% |
| Cardinal Health CAH | $59.1B | $254.2B | 14.2% | 1.0% | β | 34.5x | 2.4% |
| Henry Schein HSIC | $9.7B | $13.2B | 4.0% | 5.0% | 7.5% | 24.8x | 1.2% |